|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.71 CNY | +3.43% |
|
+5.47% | +21.34% |
| 07-13 | ApicHope Pharmaceutical Receives Shareholder Proposal from Hanxiong Li | CI |
| 06-11 | China Approves ApicHope Subsidiary's Clinical Trials for Leukemia Drug | MT |
| Market Cap | 18.26B 2.7B 2.36B 2.18B 2.01B 3.79B 259B 3.86B 25.97B 10.19B 127B 10.13B 9.9B 437B | P/E 2026 * |
35.1x | P/E 2027 * | -177x |
|---|---|---|---|---|---|
| Enterprise Value | 18.26B 2.7B 2.36B 2.18B 2.01B 3.79B 259B 3.86B 25.97B 10.19B 127B 10.13B 9.9B 437B | EV / Sales 2026 * |
16.9x | EV / Sales 2027 * | 14.5x |
| Free-Float |
31.84% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +3.43% | ||
| 1 week | +5.47% | ||
| Current month | +9.20% | ||
| 1 month | +16.08% | ||
| 3 months | +14.74% | ||
| 6 months | -2.49% | ||
| Current year | +21.34% |
| 1 week | 36.5 | 41 | |
| 1 month | 31.37 | 44.8 | |
| Current year | 29.31 | 45.88 | |
| 1 year | 29.31 | 81.48 | |
| 3 years | 12.74 | 81.48 | |
| 5 years | 12.74 | 81.48 | |
| 10 years | 7.58 | 81.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Han Xiong Li
CEO | Chief Executive Officer | 52 | 11/11/2015 |
Hui Xing Zhang
DFI | Director of Finance/CFO | 60 | 11/11/2015 |
Xiao Dong Liu
IRC | Investor Relations Contact | 38 | 31/12/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Ke Jian Zhang
BRD | Director/Board Member | 70 | 01/07/2024 |
Han Xiong Li
CHM | Chairman | 52 | 11/11/2015 |
Han Dong Li
BRD | Director/Board Member | 58 | 11/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-05 | Buy | Director | 4,200 | 0.0010% | ||
| 11-24 | Buy | Director | 7,000 | 0.0017% | ||
| 01/09/23 | Buy | 20,000 | 0.0089% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.43% | +5.47% | -24.29% | +45.65% | 2.7B | ||
| +0.46% | +3.37% | +12.98% | +81.12% | 48.52B | ||
| -0.36% | -1.79% | +66.39% | +111.26% | 35.68B | ||
| +0.10% | +0.51% | -3.47% | +39.36% | 12.09B | ||
| +2.48% | +1.18% | +20.04% | +92.62% | 11.77B | ||
| +0.94% | +0.38% | +32.83% | +126.50% | 9.19B | ||
| -1.81% | -4.04% | +43.76% | -5.22% | 7.06B | ||
| -0.83% | -0.67% | +18.12% | +36.66% | 7.01B | ||
| +0.01% | +3.67% | +3.56% | +228.20% | 6.77B | ||
| +3.56% | -6.15% | -20.01% | +13.39% | 5.98B | ||
| Average | +0.79% | +0.30% | +14.99% | +76.95% | 14.68B | |
| Weighted average by Cap. | +0.41% | -0.48% | +25.68% | +85.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.08B 159M 139M 129M 119M 224M 15.32B 228M 1.54B 603M 7.5B 599M 586M 25.82B | 1.26B 186M 162M 150M 139M 261M 17.84B 266M 1.79B 702M 8.74B 698M 682M 30.08B |
| Net income | 526M 77.66M 67.87M 62.74M 57.96M 109M 7.46B 111M 748M 294M 3.65B 292M 285M 12.58B | -102M -15.06M -13.16M -12.17M -11.24M -21.17M -1.45B -21.55M -145M -56.93M -708M -56.57M -55.32M -2.44B |
| Net Debt | - | - |
Employees
1,294
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/07/26 | CN¥40.71 | +3.43% | 19,727,349 |
| 13/07/26 | CN¥39.36 | -0.98% | 18,154,135 |
| 10/07/26 | CN¥39.75 | +5.05% | 20,104,880 |
| 09/07/26 | CN¥37.84 | +0.40% | 14,805,164 |
| 08/07/26 | CN¥37.69 | -2.36% | 13,893,809 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300723 Stock
Select your edition
All financial news and data tailored to specific country editions
















